In a huge pan-cancer dataset including ~18.000 tumors, a FOXM1 regulatory network was identified as a major predictor of adverse outcome across different tumor entities53, matching with the described link of FOXM1 with cancer therapy resistance54 and its role in DNA damage control31 as observed in stem cells and tumors like neuroblastoma. The gene discussed is FOXM1; the disease is neoplasm.